IL6 and congenital rubella syndrome: More importantly, excessive production of IL‐6 and activation of IL‐6 signaling contribute to cytokine‐release syndrome (CRS) and hyperinflammatory state but also synergize anti‐inflammatory cytokines to develop immunosuppression.6